http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
OptimizeRx’s TelaRep™ Recognized as One of the Most Innovative Products for Life Sciences by PM360
-
OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 2020
-
OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 2020
-
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
-
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
-
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
-
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
-
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500™
-
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500™
-
OptimizeRx and Questex’s Fierce Life Sciences Tackle Industry’s Top Challenges in Design Thinking Event, Innovate4Outcomes
-
OptimizeRx and Questex’s Fierce Life Sciences Tackle Industry’s Top Challenges in Design Thinking Event, Innovate4Outcomes
-
Point-of-Care Industry Expert, Angelo Campano, Joins OptimizeRx Executive Leadership as Senior Vice President and Principal of Agency Channels
-
Point-of-Care Industry Expert, Angelo Campano, Joins OptimizeRx Executive Leadership as Senior Vice President and Principal of Agency Channels
-
OptimizeRx Third Quarter 2020 Revenue Up 110% to Record $10.5 Million, Driving Non-GAAP Net Income of $1.1 million or $0.07 Per Share
-
OptimizeRx Third Quarter 2020 Revenue Up 110% to Record $10.5 Million, Driving Non-GAAP Net Income of $1.1 million or $0.07 Per Share
-
OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4:30 p.m. ET
-
OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4:30 p.m. ET
-
OptimizeRx to Participate at Investor Conferences in November
-
OptimizeRx to Participate at Investor Conferences in November
-
Optimizerx Corporation (OPRX) Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%
-
OptimizeRx Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%
-
OptimizeRx Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%
-
OptimizeRx Continues Webinar Series, Introducing Innovative Ideas for Transforming New Medication Launches
-
OptimizeRx Continues Webinar Series, Introducing Innovative Ideas for Transforming New Medication Launches
-
OptimizeRx Expands Direct-to-Patient Reach, Partnering with Epion Health to Provide Adherence and Affordability Support at Point-of-Care
-
OptimizeRx Expands Direct-to-Patient Reach, Partnering with Epion Health to Provide Adherence and Affordability Support at Point-of-Care
-
OptimizeRx to Participate at Investor Conferences in September
-
OptimizeRx to Participate at Investor Conferences in September
-
OptimizeRx to Present at the LD 500 Virtual Investor Conference on Sept. 3, 2020
-
OptimizeRx Enters Retail Pharmacies, Supporting Adherence by Bringing Prescription Savings Directly to Patients via Higi Smart Health Stations
-
OptimizeRx Enters Retail Pharmacies, Supporting Adherence by Bringing Prescription Savings Directly to Patients via Higi Smart Health Stations
-
OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second Half
-
OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second Half
-
OptimizeRx Joins with Change Healthcare to Expand Nationwide Platform Reach
-
OptimizeRx Joins with Change Healthcare to Expand Nationwide Platform Reach
-
OptimizeRx Sets Second Quarter 2020 Conference Call for Wednesday, August 5, 2020 at 4:30 p.m. ET
-
OptimizeRx Sets Second Quarter 2020 Conference Call for Wednesday, August 5, 2020 at 4:30 p.m. ET
-
OptimizeRx Appoints Greg Wasson, Former President and CEO of Walgreens Boots Alliance, to Its Board of Directors
-
OptimizeRx Appoints Greg Wasson, Former President and CEO of Walgreens Boots Alliance, to Its Board of Directors
-
OptimizeRx Sales Momentum Continues with Two New Enterprise-level Engagements Added to its Digital Health Platform
-
OptimizeRx Sales Momentum Continues with Two New Enterprise-level Engagements Added to its Digital Health Platform
-
OptimizeRx Engages UHY as New Independent Registered Public Accounting Firm
-
OptimizeRx Engages UHY as New Independent Registered Public Accounting Firm
-
OptimizeRx Digital Health Platform Adds More than 300 Epic and Cerner Health Systems
-
OptimizeRx Digital Health Platform Adds More than 300 Epic and Cerner Health Systems
-
OptimizeRx to Present at William Blair & Company's 40th Annual Growth Stock Conference, June 9-11, 2020
-
OptimizeRx to Present at William Blair & Company's 40th Annual Growth Stock Conference, June 9-11, 2020
-
OptimizeRx to Present at RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2020
-
OptimizeRx to Present at RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2020
-
OptimizeRx Empowers Patients and Providers with Telemedicine Tools Tailored for Women’s Health
